PRECLINICAL ANTITUMOR-ACTIVITY OF 5-AZA-2'-DEOXYCYTIDINE AGAINST HUMAN HEAD AND NECK-CANCER XENOGRAFTS

被引：15

作者：

BRAAKHUIS, BJM ^{[1
]}

VANDONGEN, GAMS ^{[1
]}

VANWALSUM, M ^{[1
]}

LEYVA, A ^{[1
]}

SNOW, GB ^{[1
]}

机构：

[1] FREE UNIV AMSTERDAM HOSP,DEPT ONCOL,1081 HV AMSTERDAM,NETHERLANDS

来源：

INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 04期

关键词：

D O I：

10.1007/BF00173648

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：299 / 304

页数：6

共 19 条

[1] CHEMOTHERAPY OF HUMAN HEAD AND NECK-CANCER XENOGRAFTS WITH 3 CLINICALLY ACTIVE-DRUGS - CIS-PLATINUM, BLEOMYCIN AND METHOTREXATE
BRAAKHUIS, BJM
SCHOEVERS, EJ
HEINERMAN, ECM
SNEEUWLOPER, G
SNOW, GB
[J]. BRITISH JOURNAL OF CANCER, 1983, 48 (05) : 711 - 716
[2] THE POTENTIAL OF THE NUDE-MOUSE XENOGRAFT MODEL FOR THE STUDY OF HEAD AND NECK-CANCER
BRAAKHUIS, BJM
SNEEUWLOPER, G
SNOW, GB
[J]. ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE, 1984, 239 (01): : 69 - 79
[3] COMPARISON OF THE INVITRO CYTO-TOXICITY (L1210) OF 5-AZA-2'-DEOXYCYTIDINE WITH ITS THERAPEUTIC AND TOXIC EFFECTS IN MICE
COVEY, JM
ZAHARKO, DS
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (01): : 109 - 117
[4] COVEY JM, 1986, CANCER RES, V46, P5511
[5] CREUSOT F, 1982, J BIOL CHEM, V257, P2041
[6] CHARACTERIZATION OF 2 MONOCLONAL-ANTIBODIES TO HUMAN EPIDERMAL KERATOHYALIN - REACTIVITY WITH FILAGGRIN AND RELATED PROTEINS
DALE, BA
GOWN, AM
FLECKMAN, P
KIMBALL, JR
RESING, KA
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (03) : 306 - 313
[7] DINCALCI M, 1985, CANCER RES, V45, P3197
[8] FIEBIG H H, 1984, Digestive Surgery, V1, P225, DOI 10.1159/000171659
[9] GROWTH INHIBITORY EFFECTS OF 5-AZA-2'-DEOXYCYTIDINE IN HL-60 PROMYELOCYTIC LEUKEMIA-CELLS RESISTANT TO DIFFERENTIATION INDUCTION
LEYVA, A
SCHWARTSMANN, G
BOEIJE, LCM
PINEDO, HM
DEWAAL, F
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (02) : 629 - 635
[10] CELL-CYCLE EFFECTS AND CELLULAR PHARMACOLOGY OF 5-AZA-2'-DEOXYCYTIDINE
MOMPARLER, RL
SAMSON, J
MOMPARLER, LF
RIVARD, GE
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) : 191 - 194

← 1 2 →